Clinical trials
Phase 1/2 Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Florida | 2 |
| Anaveon AG | 1 |
| Atavistik Bio, Inc | 1 |
| Biomoda Inc. | 1 |
| Chimagen Biosciences, Ltd | 1 |
| Columbia University | 1 |
| Massachusetts General Hospital | 1 |
| Mayo Clinic | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| RayzeBio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease | 15 |
| Cardiovascular Diseases | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Alcoholism | 1 |
| Alzheimer Disease | 1 |
| Anemia, Sickle Cell | 1 |
| Arteriovenous Malformations | 1 |
| Autoimmune Diseases | 1 |
| Brain Diseases | 1 |
| COVID-19 | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.